Abstract
The aim of this study is to evaluate efficacy and tolerability of zonisamide (ZNS), a new - generation anticonvulsant recently available in Italy, in a population of drug-resistant epileptic patients.
Translated title of the contribution | Zonisamide efficacy and tolerability in drug-resistant patients: A multicenter study |
---|---|
Original language | Italian |
Pages (from-to) | 279-280 |
Number of pages | 2 |
Journal | Bollettino - Lega Italiana contro l'Epilessia |
Issue number | 138 |
Publication status | Published - 2008 |
ASJC Scopus subject areas
- Clinical Neurology